Indication
Typhoid
4 clinical trials
13 products
Clinical trial
A Randomised, Double-blind, Placebo-controlled, Single Dose, Dose Escalation Study to Determine the Immunogenicity, Safety and Tolerability of S. Typhi (Ty2 aroC-ssaV-) ZH9 at Doses of 5.0 x 10E9 CFU, 7.5 x 10E9 CFU, 1.1 x 10E10 and 1.7 x 10E10 CFU and 1.7 x 10E10 CFU, Following Oral Administration to Healthy, Typhoid Vaccine naïve Subjects in the USA.Status: Completed, Estimated PCD: 2008-12-01
Product
CFUProduct
Dose of 7.5 x 10^9 CFUProduct
1.1 x 10^10 CFUProduct
1.7 x 10^10 CFUProduct
Dose of 5.0 x 10^9 CFUClinical trial
A Co-administration Study of Oral Cholera Vaccine (OCV), Typhoid Conjugate Vaccine (TCV), Measles and Rubella (MR) Vaccines in BangladeshStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Product
Oral Cholera VaccineProduct
Typhoid Conjugate VaccineProduct
Measles and RubellaClinical trial
A Phase III Randomized, Double-Blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiStatus: Active (not recruiting), Estimated PCD: 2024-10-30
Product
Vi-Typhoid Conjugate VaccineClinical trial
Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control.Status: Completed, Estimated PCD: 2015-12-01
Product
Vaccine placeboProduct
Ty21aProduct
M10ZH09 vaccine